- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 1.34M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.3M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.26M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $6K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$10.73M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$7.09M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $152.33M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$137.29M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $18.59M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $31.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $38.39M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $14.19M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.25M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $14.19M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.31M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $204.23M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $21.51M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $205.38M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $22.9M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$131.45 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$5.45 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$131.45 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$5.45 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $19.71M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.55M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$170.24M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.86M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$170.63M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$7.27M |